Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4486 AL 4500

Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer's disease

Ryan SM, Kelly ÁM.

Ageing Res Rev. 2016 May;27:77-92. doi: 10.1016/j.arr.2016.03.007. Epub 2016 Mar 31.

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

Darvesh S.

Curr Alzheimer Res. 2016;13(10):1173-7. doi: 10.2174/1567205013666160404120542.

Alzheimer Disease

Apostolova LG.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):419-34. doi: 10.1212/CON.0000000000000307.

Patient Management Problem

Finger EC.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):674-8, 679-88. doi: 10.1212/CON.0000000000000314.

Exploring psychosocial interventions for people with dementia that enhance personhood and relate to legacy- an integrative review

Johnston B, Narayanasamy M.

BMC Geriatr. 2016 Apr 5;16:77. doi: 10.1186/s12877-016-0250-1.

People with dementia in nursing home research: a methodological review of the definition and identification of the study population

Palm R, Jünger S, Reuther S, Schwab CG, Dichter MN, Holle B, Halek M.

BMC Geriatr. 2016 Apr 5;16:78. doi: 10.1186/s12877-016-0249-7.

[Methylphenidate in a patient with Alzheimer's disease : Increase in drive and cardiac performance]

Schuhfried G, Schuhfried G.

Z Gerontol Geriatr. 2017 Jun;50(4):362-364. doi: 10.1007/s00391-016-1043-z. Epub 2016 Apr 13.

Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach

Schelke MW, Hackett K, Chen JL, Shih C, Shum J, Montgomery ME, Chiang GC, Berkowitz C, Seifan A, Krikorian R, Isaacson RS.

Ann N Y Acad Sci. 2016 Mar;1367(1):50-6. doi: 10.1111/nyas.13070.

Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness

Imbeault H, Gagnon L, Pigot H, Giroux S, Marcotte N, Cribier-Delande P, Duval J, Bocti C, Lacombe G, Fülöp T, Bier N.

Neuropsychol Rehabil. 2018 Jul;28(5):755-778. doi: 10.1080/09602011.2016.1172491. Epub 2016 Apr 28.

Neurosurgical treatment of Alzheimer's disease: where do we stand?

Lavano A.

J Neurosurg Sci. 2016 Jun;60(2):151-3.

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition

Kantarci K, Lowe VJ, Lesnick TG, Tosakulwong N, Bailey KR, Fields JA, Shuster LT, Zuk SM, Senjem ML, Mielke MM, Gleason C, Jack CR, Rocca WA, Miller VM.

J Alzheimers Dis. 2016 May 7;53(2):547-56. doi: 10.3233/JAD-160258.

[No longer an individual fate]

Hoffmann R.

Pflege Z. 2016 Mar;69(3):129.

Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of Biomarkers

Deguil J, Ravasi L, Lamberty Y, Auffret A, Payoux P, Leroy C, Derambure P, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):823-36. doi: 10.2174/1871527315666160518124759.

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

Martorana A, Giacalone V, Bonsignore R, Pace A, Gentile C, Pibiri I, Buscemi S, Lauria A, Piccionello AP.

Curr Pharm Des. 2016;22(26):3971-95. doi: 10.2174/1381612822666160518141650.

Editorial: Towards New Approaches in Alzheimer's Research and Alzheimer's Disease

Mai S.

Curr Alzheimer Res. 2016;13(7):728-9. doi: 10.2174/156720501307160511233345.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias